ArticleBMC psychiatry2026
The relationship between serum inflammatory cytokine levels and subjective sleep quality in chronic insomnia disorder.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Biomarker evidence for the pathophysiological mechanisms of insomnia: a systematic review and meta-analysis.Frontiers in immunology · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundSleep disturbances have increasingly been linked to dysregulation of the immune-inflammatory system. However, evidence regarding such alterations in patients with chronic insomnia disorder (CID) remains limited. This study aimed to characterize the inflammatory cytokine profile of CID and to investigate its association with subjective sleep quality.
methodsThirty-two patients with CID were recruited from the Sleep Medicine Center at the First Affiliated Hospital of Jinan University between January 2024 and June 2025, along with 31 community-recruited healthy controls. Depressive symptoms, anxiety symptoms, and subjective sleep quality were assessed using the 17-item Hamilton Depression Rating Scale (HAMD-17), Hamilton Anxiety Rating Scale (HAMA), and Pittsburgh Sleep Quality Index (PSQI), respectively. Serum levels of IL-1β, CRP, IL-6, IL-8, IFN-γ, TNF-α, and IL-10 were measured using enzyme-linked immunosorbent assay (ELISA). Finally, Spearman correlation and receiver operating characteristic (ROC) analyses were performed.
resultsCompared with healthy controls, patients with CID had higher IL-1β and IFN-γ levels and lower IL-10 levels (all P < 0.05). IL-1β levels were positively correlated with the PSQI total score (r = 0.429, P = 0.003), whereas IL-10 levels were negatively correlated with the PSQI total score (r = - 0.540, P = 0.013). ROC analyses showed that IL-1β alone (AUC = 0.752; 95% CI: 0.635-0.869; P < 0.001) and a combined model incorporating IL-1β, IFN-γ, and IL-10 (AUC = 0.752; 95% CI: 0.637-0.867; P < 0.001) had comparable discriminative performance for CID.
conclusionsPatients with CID exhibit altered inflammatory cytokine levels, and some of these alterations were associated with subjective sleep quality, suggesting that immune-inflammatory dysregulation may be involved in the pathophysiology of CID. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.